REGN
Regeneron Pharmaceuticals Inc.
$642.55
-$9.25(-1.42%)
69
Overall
80
Value
72
Tech
55
Quality
Market Cap
$61.26B
Volume
443.36K
52W Range
$476.49 - $852.01
Target Price
$756.38
Key Metrics Overview
| Market Cap | $61.26B | P/E Ratio | 18.45 |
| 52W High | $852.01 | 52W Low | $476.49 |
| Div Yield | 352.0% | Payout Ratio | 18.3% |
| EPS Growth 3Y | -18.8% | 52W Position | 44.2% |
| Overall Score | 69 | Value Score | 80 |
| Quality Score | 55 | Technical Score | 72 |
Growth Analysis
| EPS Current Est | $34.82 | EPS Next Est | $32.5 |
| EPS Growth Est | -6.7% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | REGN | $642.55 | -1.4% | 443.36K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Regeneron Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW